Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 19184495 | SYSTEMS AND METHODS FOR ULTRASONIC GUIDED NEEDLE INSERTION | April 2025 | August 2025 | Allow | 4 | 1 | 0 | Yes | No |
| 18984429 | Needle Guidance System | December 2024 | January 2026 | Allow | 13 | 1 | 0 | No | No |
| 18829655 | ENDOSCOPE BALLOON, ENDOSCOPE BALLOON UNIT, AND ENDOSCOPE | September 2024 | March 2026 | Allow | 18 | 1 | 0 | Yes | No |
| 18813602 | INCOHERENT FIELD SONODYNAMIC THERAPY FOR TREATING CANCER | August 2024 | March 2026 | Allow | 19 | 1 | 0 | No | No |
| 18780443 | ULTRASONIC ENDOSCOPE AND MANUFACTURING METHOD OF ULTRASONIC ENDOSCOPE | July 2024 | February 2026 | Allow | 19 | 1 | 0 | Yes | No |
| 18778868 | ULTRASOUND DIAGNOSTIC SYSTEM | July 2024 | December 2025 | Allow | 17 | 1 | 0 | No | No |
| 18568038 | MINIMALLY INVASIVE HISTOTRIPSY SYSTEMS AND METHODS | December 2023 | November 2025 | Allow | 23 | 1 | 0 | No | No |
| 18359417 | SYSTEMS AND METHODS FOR WIRELESS LOCALIZATION | July 2023 | June 2025 | Allow | 22 | 3 | 0 | No | No |
| 18215497 | INCOHERENT FIELD SONODYNAMIC THERAPY FOR TREATING CANCER | June 2023 | May 2024 | Allow | 11 | 2 | 0 | Yes | No |
| 18144772 | ROLLED FLEXIBLE SUBSTRATE WITH INTEGRATED WINDOW FOR INTRALUMINAL ULTRASOUND IMAGING DEVICE | May 2023 | October 2025 | Allow | 29 | 5 | 0 | Yes | No |
| 18188111 | ULTRASOUND DIAGNOSTIC APPARATUS AND OPERATION METHOD THEREOF | March 2023 | May 2025 | Allow | 26 | 2 | 0 | No | No |
| 18169836 | MEDICAL SYSTEM | February 2023 | February 2026 | Allow | 36 | 1 | 0 | No | No |
| 18021096 | A MEDICAL APPARATUS FOR THE NON-INVASIVE TRANSMISSION OF FOCUSSED SHEAR WAVES TO IMPACT CELLULAR BEHAVIOUR | February 2023 | September 2025 | Allow | 32 | 2 | 0 | Yes | No |
| 18106889 | BODY VESSEL NAVIGATION SYSTEM | February 2023 | February 2025 | Abandon | 25 | 1 | 0 | No | No |
| 17979315 | TARGET APPARATUS FOR USE IN A SURGICAL NAVIGATION SYSTEM, SURGICAL NAVIGATION SYSTEM, AND METHOD FOR PRODUCING SUCH A TARGET APPARATUS | November 2022 | December 2025 | Abandon | 37 | 1 | 1 | No | No |
| 18048780 | Needle Guidance System | October 2022 | December 2024 | Allow | 26 | 5 | 0 | Yes | No |
| 17901900 | Physiological Acquisition System For Use In An RF-Shielded Room | September 2022 | September 2024 | Allow | 25 | 0 | 0 | No | No |
| 17800766 | REAL-TIME AI FOR PHYSICAL BIOPSY MARKER DETECTION | August 2022 | June 2025 | Abandon | 34 | 2 | 0 | No | No |
| 17797595 | ULTRASONIC PROBE AND MANUFACTURING METHOD THEREFOR | August 2022 | March 2025 | Allow | 32 | 3 | 0 | Yes | No |
| 17748237 | DEVICES, SYSTEMS, AND METHODS FOR REDUCING SIGNAL NOISE IN ENDOSCOPIC ROTATIONAL IMAGING | May 2022 | May 2024 | Allow | 24 | 2 | 0 | Yes | No |
| 17725196 | ROBOTIC SURGERY | April 2022 | June 2025 | Abandon | 38 | 2 | 0 | No | No |
| 17720764 | SYSTEMS AND METHODS FOR THE ASSESSMENT OF CARDIAC AMYLOIDOSIS | April 2022 | September 2025 | Allow | 41 | 2 | 0 | Yes | No |
| 17765906 | PARALLEL PATH PUNCTURE DEVICE GUIDE | April 2022 | December 2023 | Allow | 20 | 1 | 0 | Yes | No |
| 17761430 | MULTI-SEGMENT INTRALUMINAL IMAGING DEVICE AND ASSOCIATED DEVICES, SYSTEMS, AND METHODS | March 2022 | July 2025 | Abandon | 40 | 5 | 0 | Yes | No |
| 17533270 | DUAL BRILLOUIN-PHOTOACOUSTIC MICROSCOPY | November 2021 | March 2025 | Allow | 40 | 4 | 1 | Yes | No |
| 17601101 | 3D LASER-ASSISTED POSITIONING SYSTEM | October 2021 | April 2025 | Abandon | 42 | 2 | 0 | No | No |
| 17310696 | SYSTEMS AND METHODS FOR PERFORMING MAGNETIC RESONANCE IMAGING | August 2021 | November 2024 | Abandon | 39 | 2 | 0 | No | No |
| 17431521 | STATE ESTIMATION APPARATUS, STATE ESTIMATION METHOD, AND COMPUTER READABLE RECORDING MEDIUM | August 2021 | March 2025 | Allow | 43 | 2 | 0 | Yes | No |
| 17427044 | BLOOD-PRESSURE MEASUREMENT DEVICE, MODEL SETTING DEVICE, AND BLOOD-PRESSURE MEASUREMENT METHOD | July 2021 | May 2025 | Abandon | 45 | 2 | 0 | No | No |
| 17298219 | INTERLEAVED LIGHT SOURCES AND METHODS OF THEIR USE | May 2021 | March 2025 | Abandon | 46 | 2 | 0 | No | No |
| 17303295 | ULTRASOUND PROBE WITH ADJUSTABLE APERTURE | May 2021 | December 2023 | Allow | 31 | 3 | 1 | Yes | No |
| 17222376 | METHODS AND SYSTEMS FOR AN INVASIVE DEPLOYABLE DEVICE | April 2021 | December 2023 | Abandon | 32 | 2 | 0 | No | No |
| 17249873 | ULTRASOUND TRANSDUCER ASSEMBLY, PROBE, ENDOSCOPY SYSTEM AND MANUFACTURING METHOD | March 2021 | July 2024 | Abandon | 40 | 3 | 1 | No | No |
| 17266574 | INTERVENTIONAL DEVICE WITH AN ULTRASOUND TRANSDUCER | February 2021 | September 2024 | Abandon | 43 | 5 | 1 | Yes | Yes |
| 17259033 | Acousto-Optical Sensors for MRI Safety Evaluation | January 2021 | October 2024 | Abandon | 45 | 1 | 1 | No | No |
| 17117731 | CLOSED-LOOP TOOL CONTROL FOR ORTHOPEDIC SURGICAL PROCEDURES | December 2020 | January 2025 | Abandon | 49 | 3 | 0 | Yes | No |
| 17101254 | MEDICAL IMAGE PROCESSING APPARATUS | November 2020 | January 2025 | Allow | 50 | 3 | 0 | Yes | No |
| 17080467 | Adaptive Selection of Ultrasound Frequency | October 2020 | October 2023 | Allow | 36 | 2 | 0 | Yes | No |
| 17079274 | ULTRASOUND IMAGING METHOD AND ULTRASOUND IMAGING DEVICE | October 2020 | June 2025 | Abandon | 55 | 6 | 0 | Yes | No |
| 17079118 | IMAGE PROCESSING APPARATUS, IMAGE PROCESSING METHOD, AND IMAGE PROCESSING PROGRAM | October 2020 | March 2025 | Allow | 53 | 4 | 1 | Yes | No |
| 17073159 | ULTRASOUND PROBE WITH IMPROVED THERMAL MANAGEMENT | October 2020 | January 2026 | Allow | 60 | 4 | 1 | No | Yes |
| 17039062 | DEVICES, SYSTEMS, AND METHODS FOR IMAGING WITHIN A BODY LUMEN | September 2020 | January 2024 | Allow | 40 | 5 | 1 | Yes | No |
| 17030026 | Probe Shield | September 2020 | March 2025 | Allow | 54 | 7 | 1 | Yes | Yes |
| 17025622 | MULTI-FREQUENCY MAPPING CATHETER AND METHOD OF MAPPING | September 2020 | October 2023 | Allow | 37 | 4 | 0 | Yes | No |
| 16979964 | BREAST ULTRASOUND WORKFLOW APPLICATION | September 2020 | September 2024 | Allow | 48 | 5 | 1 | Yes | No |
| 16964249 | A method for Preparing an Insertion Site for a Cannula on a Skin of a Patient, a Skin Cover Unit Therefore and Its Use | July 2020 | December 2023 | Allow | 41 | 5 | 0 | Yes | No |
| 16922204 | ENDOVASCULAR OCCLUSION DEVICE AND METHOD OF USE | July 2020 | July 2024 | Abandon | 49 | 4 | 0 | Yes | No |
| 16905873 | ULTRASONIC ENDOSCOPE AND MANUFACTURING METHOD OF ULTRASONIC ENDOSCOPE | June 2020 | April 2024 | Allow | 46 | 4 | 1 | Yes | No |
| 16894421 | Pattern Interference Radiation Force (PIRF) neural stimulators | June 2020 | August 2024 | Allow | 50 | 2 | 0 | No | No |
| 16879519 | DUAL LAYER ULTRASONIC TRANSDUCER | May 2020 | August 2024 | Abandon | 51 | 6 | 0 | Yes | No |
| 16641671 | ABLATION CATHETER, CATHETER ARRANGEMENT AND SYSTEM FOR PROVIDING ABLATIVE TREATMENT | February 2020 | May 2024 | Abandon | 51 | 6 | 0 | Yes | No |
| 16795220 | IDENTIFICATION OF RESPIRATORY PHASES IN A MEDICAL PROCEDURE | February 2020 | July 2024 | Abandon | 52 | 6 | 0 | Yes | No |
| 16773912 | SYSTEMS AND METHODS FOR USING LOW INTENSITY ULTRASONIC TRANSDUCER ON THE BRAIN | January 2020 | August 2025 | Abandon | 60 | 5 | 1 | No | No |
| 16631802 | RF Based Monitoring Of User Activity | January 2020 | February 2025 | Allow | 60 | 7 | 0 | Yes | No |
| 16625104 | METHOD FOR PROCESSING ULTRASONIC IMAGE | December 2019 | June 2024 | Abandon | 54 | 4 | 0 | Yes | No |
| 16623974 | ASSEMBLY FOR IMAGING AND/OR TREATING BRAIN TISSUE | December 2019 | May 2024 | Allow | 53 | 5 | 0 | No | No |
| 16662595 | INTRALUMINAL ULTRASOUND NAVIGATION GUIDANCE AND ASSOCIATED DEVICES, SYSTEMS, AND METHODS | October 2019 | October 2024 | Allow | 60 | 7 | 0 | Yes | No |
| 16565219 | Ultrasound Transducer Array Architecture And Method of Manufacture | September 2019 | June 2024 | Allow | 57 | 5 | 0 | Yes | Yes |
| 16491110 | IMAGING ASSEMBLY FOR INTRALUMINAL IMAGING | September 2019 | December 2025 | Allow | 60 | 6 | 0 | Yes | Yes |
| 16477060 | STRETCHABLE ULTRASONIC TRANSDUCER DEVICES | July 2019 | March 2025 | Allow | 60 | 7 | 1 | Yes | No |
| 16475675 | LOCALIZED MAGNETIC FIELD GENERATOR | July 2019 | January 2025 | Allow | 60 | 6 | 1 | Yes | No |
| 16369783 | MEDICAL DIAGNOSIS APPARATUS, MEDICAL IMAGE PROCESSING APPARATUS, AND IMAGE PROCESSING METHOD | March 2019 | February 2024 | Abandon | 59 | 7 | 0 | No | No |
| 16336544 | ELECTRICAL GROUNDING FOR IMAGING ASSEMBLY AND ASSOCIATED INTRALUMINAL DEVICES, SYSTEMS, AND METHODS | March 2019 | December 2023 | Allow | 57 | 6 | 0 | Yes | No |
| 16267833 | SURGICAL ROBOT PLATFORM | February 2019 | May 2024 | Abandon | 60 | 4 | 0 | No | No |
| 16266442 | System and Method for a Wearable Vital Signs Monitor | February 2019 | January 2024 | Allow | 60 | 3 | 0 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner FANG, MICHAEL YIMING.
With a 100.0% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 33.3% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.
✓ Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Examiner FANG, MICHAEL YIMING works in Art Unit 3798 and has examined 41 patent applications in our dataset. With an allowance rate of 56.1%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 50 months.
Examiner FANG, MICHAEL YIMING's allowance rate of 56.1% places them in the 17% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by FANG, MICHAEL YIMING receive 4.29 office actions before reaching final disposition. This places the examiner in the 98% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by FANG, MICHAEL YIMING is 50 months. This places the examiner in the 6% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +41.8% benefit to allowance rate for applications examined by FANG, MICHAEL YIMING. This interview benefit is in the 88% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 11.2% of applications are subsequently allowed. This success rate is in the 6% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 19.5% of cases where such amendments are filed. This entry rate is in the 23% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants request a pre-appeal conference (PAC) with this examiner, 200.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 100% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.
This examiner withdraws rejections or reopens prosecution in 66.7% of appeals filed. This is in the 52% percentile among all examiners. Of these withdrawals, 50.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.
When applicants file petitions regarding this examiner's actions, 0.0% are granted (fully or in part). This grant rate is in the 7% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 49% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 51% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.